Basic Information
Basic information for C8orf34-AS1-209-40aa-1
Peptide Name C8orf34-AS1-209-40aa-1
Genome Position chr8:68303020-68303139[-]
Species Human
Peptide Sequence MNANIHSAPIFLLFHVFTPELIYYLLYAFESKLQTSACFS
Peptide Length 40
Unique No (C8orf34-AS1-201-40aa,C8orf34-AS1-203-40aa-1,C8orf34-AS1-204-40aa-1,C8orf34-AS1-205-40aa-1,C8orf34-AS1-206-40aa,C8orf34-AS1-207-40aa,C8orf34-AS1-208-40aa-1,C8orf34-AS1-210-40aa)
Grand Average of Hydropathicity 0.665
Relative Molecular Mass 5344.03
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000248801;C8orf34-AS1
Transcript ID/Name ENST00000660308;C8orf34-AS1-209
Transcript Length 2842
Coding Ability 0.3624
DNA Sequence Corresponding to Peptide ATGAATGCTAATATACACTCAGCACCTATATTCTTGCTTTTTCATGTATTTACTCCTGAATTAATATATTACTTGTTATATGCTTTTGAAAGTAAACTGCAAACAAGTGCATGCTTCTCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :